<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1.0," />

<title>Argatroban Dosing Calculator</title>
<link href="argatroban.css" rel="stylesheet" type="text/css">
<script language="JavaScript" src="jquery-1.7.2.min.js" type="text/javascript"></script>
 
<script type="text/javascript">  
 window.onorientationchange = detectIPadOrientation;  
 function detectIPadOrientation () {  
  
    if ( orientation == 0 ) {  
      document.getElementsByTagName("body")[0].style.webkitTransform = "rotate(-90deg)";
	  document.getElementsByTagName("body")[0].style.left = "-380px";
	  document.getElementsByTagName("body")[0].style.top = "544px";  
    }  
    else if ( orientation == 90 ) {  
     document.getElementsByTagName("body")[0].style.webkitTransform = "rotate(0deg)";
	  document.getElementsByTagName("body")[0].style.left = "0px";
	  document.getElementsByTagName("body")[0].style.top = "0px"; 
    }  
    else if ( orientation == -90 ) {  
     document.getElementsByTagName("body")[0].style.webkitTransform = "rotate(0deg)";
	  document.getElementsByTagName("body")[0].style.left = "0px";
	  document.getElementsByTagName("body")[0].style.top = "0px"; 
    }  
    else if ( orientation == 180 ) {  
    document.getElementsByTagName("body")[0].style.webkitTransform = "rotate(90deg)";
	  document.getElementsByTagName("body")[0].style.left = "384px";
	  document.getElementsByTagName("body")[0].style.top = "310px"; 
    }  
 }  
</script> 
<!--<script language="JavaScript" src="http://code.jquery.com/mobile/1.2.1/jquery.mobile-1.2.1.js" type="text/javascript"></script>-->
    <script src="phonegap.js"></script>
</head>

<body>

<div class="container">
<div class="title">
<h2>Argatroban Brief Prescribing Information</h2>
</div><!-- title -->

<div class="centerTablePI">

<div id="PI">
<h4>HIGHLIGHTS  OF PRESCRIBING INFORMATION</h4>
<p>These highlights do  not include all the information needed to use Argatroban Injection safely and  effectively. <br>
  See full prescribing information for Argatroban Injection. </p>
<p>ARGATROBAN INJECTION,  for intravenous use
<br>Initial U.S.  Approval: 2000</p>
<h4>______________________CONTRAINDICATIONS_____________________</h4>
<ul>
<li>Patients with major bleeding</li>
<li>Patients with a history of hypersensitivtiy to argatroban</li>
</ul>
<h4>__________________WARNINGS AND PRECAUTIONS_________________</h4>
<ul>
<li>Risk of hemorrhage: Major or minor bleeding can occur. Use with caution in patients at risk, including those receiving antiplatelet agents, thrombolytics, or other anticoagulants.
</li>
<li>Use in hepatic impairment: Adjust starting dose and titrate carefully in patients with HIT who have moderate or severe hepatic impairment. Avoid use in PCI in patients with clinically significant hepatic impairment.</li>
</ul>
<h4>_____________________ADVERSE REACTIONS______________________</h4>
<ul class="adverse">
<li>HIT patients - The most common (> 5%) adverse reactions were dyspnea, hypotension, fever, diarrhea, sepsis, and cardiac arrest.</li>
<li>Adjust dose to achieve steady-state aPTT of  1.5-3 times the baseline value (not to exceed 100 seconds), without exceeding a  rate of 10 mcg/kg/minute. PCI patients - The most common (> 5%) adverse reactions were chest pain, hypotension, back pain, nausea, vomiting, and headache.</li>
</ul>
<p>For more detailed adverse event information, see full prescribing information.
Percutaneous Coronary  Intervention<br>
<b>To report SUSPECTED ADVERSE REACTIONS, contact Baxter at 1-866-888-2472 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch</b></p>
<h4>______________________DRUG INTERACTIONS_____________________</h4>
<ul>
<li>Heparin: Allow sufficient time for heparin's effect on aPTT to decrease before initiating Argatroban Injection therapy.</li>
<li>Warfarin: Concomitant use results in increased prolongation of PT and INR.</li>
<li>Thrombolytic agents or glycoprotein IIb/IIIa antagonists: Safety and effectiveness of concomitant use with argatroban have not been established.</li>
</ul>
<h4>__________________USE IN SPECIFIC POPULATIONS_________________</h4>
<ul>
<li>Nursing Mothers: Discontinue nursing or drug, taking into account the importance of the drug to the mother.</li>
<li>Pediatric Use: Safety and effectiveness have not been established; if used initial infusion doses are lower than in adult patients.</li>
</ul>
<h4>See FULL PRESCRIBING INFORMATION for PATIENT COUNSELING INFORMATION</h4>

<div><!-- PI -->

</div><!-- centerTable -->

<div class="navigationPI2">
  <a href="index5.html"><img src="images/button_prev.png" width="106" height="60" alt="previous"></a>
  </div><!-- navigation -->

</div><!-- container -->

</body>
</html>
